Zebra Capital Management’s Niagen Bioscience, Inc. Common Stock NAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-24,194
| Closed | -$90K | – | 182 |
|
|
2021
Q4 | $90K | Buy |
24,194
+1,174
| +5% | +$4.37K | 0.14% | 145 |
|
|
2021
Q3 | $144K | Hold |
23,020
| – | – | 0.17% | 162 |
|
|
2021
Q2 | $227K | Buy |
23,020
+737
| +3% | +$7.27K | 0.27% | 127 |
|
|
2021
Q1 | $208K | Sell |
22,283
-57,544
| -72% | -$537K | 0.23% | 148 |
|
|
2020
Q4 | $383K | Sell |
79,827
-2,963
| -4% | -$14.2K | 0.49% | 91 |
|
|
2020
Q3 | $332K | Buy |
82,790
+56,083
| +210% | +$225K | 0.51% | 88 |
|
|
2020
Q2 | $123K | Sell |
26,707
-623
| -2% | -$2.87K | 0.18% | 184 |
|
|
2020
Q1 | $89K | Sell |
27,330
-1,389
| -5% | -$4.52K | 0.14% | 186 |
|
|
2019
Q4 | $123K | Buy |
+28,719
| New | +$123K | 0.11% | 255 |
|